Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories

M Fiegl; M Erdel; I Tinhofer; G Hopfinger; K Eigenberger; F Falkner; A Falkner; Y Brychtova; A Panovska; M Doubek; A Zabernigg; Sigrun Sodia-Feldner; H Muhlberger; G Gastl; J Mayer; R Greil

Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories

M Fiegl
, M Erdel
, I Tinhofer
, G Hopfinger
, K Eigenberger
, F Falkner
, A Falkner
, Y Brychtova
, A Panovska
, M Doubek
, A Zabernigg
, Sigrun Sodia-Feldner
, H Muhlberger
, G Gastl
, J Mayer
, R Greil

Diagnostik- & Forschungsinstitut für Humangenetik

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

Originalsprache	Englisch
Fachzeitschrift	Blood
Publikationsstatus	Veröffentlicht - 2008
Veranstaltung	50th Annual Meeting of the American Society of Hematology - San Francisco, USA/Vereinigte Staaten Dauer: 6 Dez. 2008 → 9 Dez. 2008

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

305 Andere Humanmedizin, Gesundheitswissenschaften
302 Klinische Medizin

Andere Dateien und Links

Web of Science

Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories
Fiegl, M. (Autor*in), Erdel, M. (Autor*in), Tinhofer, I. (Autor*in), Hopfinger, G. (Autor*in), Eigenberger, K. (Autor*in), Falkner, F. (Autor*in), Falkner, A. (Autor*in), Brychtova, Y. (Autor*in), Panovska, A. (Autor*in), Doubek, M. (Autor*in), Zabernigg, A. (Autor*in), Sodia-Feldner, S. (Autor*in), Muhlberger, H. (Autor*in), Gastl, G. (Autor*in), Mayer, J. (Autor*in) & Greil, R. (Autor*in)
2008
Aktivität: Vortrag oder Poster › Poster

Dieses zitieren

Fiegl, M., Erdel, M., Tinhofer, I., Hopfinger, G., Eigenberger, K., Falkner, F., Falkner, A., Brychtova, Y., Panovska, A., Doubek, M., Zabernigg, A., Sodia-Feldner, S., Muhlberger, H., Gastl, G., Mayer, J., & Greil, R. (2008). Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories. Blood.

@article{9e36c81859a94f02b0ac916d2b5c591f,

title = "Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories",

author = "M Fiegl and M Erdel and I Tinhofer and G Hopfinger and K Eigenberger and F Falkner and A Falkner and Y Brychtova and A Panovska and M Doubek and A Zabernigg and Sigrun Sodia-Feldner and H Muhlberger and G Gastl and J Mayer and R Greil",

year = "2008",

language = "English",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

note = "50th Annual Meeting of the American Society of Hematology, ASH 50 ; Conference date: 06-12-2008 Through 09-12-2008",

}

TY - JOUR

T1 - Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories

AU - Fiegl, M

AU - Erdel, M

AU - Tinhofer, I

AU - Hopfinger, G

AU - Eigenberger, K

AU - Falkner, F

AU - Falkner, A

AU - Brychtova, Y

AU - Panovska, A

AU - Doubek, M

AU - Zabernigg, A

AU - Sodia-Feldner, Sigrun

AU - Muhlberger, H

AU - Gastl, G

AU - Mayer, J

AU - Greil, R

PY - 2008

Y1 - 2008

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000262104703601

M3 - Conference abstract

SN - 0006-4971

JO - Blood

JF - Blood

T2 - 50th Annual Meeting of the American Society of Hematology

Y2 - 6 December 2008 through 9 December 2008

ER -

Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories

UN SDGs

Wissenschaftszweige

Andere Dateien und Links

Aktivitäten

Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Therapy: Retrospective Study within Various Cytogenetic Risk Categories

Dieses zitieren